A Phase 1 Study of TAK-676, a Novel STING Agonist, Plus Pembrolizumab Following Radiation Therapy in Patients with Advanced Non–Small-Cell Lung Cancer (NSCLC), Triple-Negative Breast Cancer (TNBC), or Squamous-Cell Carcinoma of the Head and Neck (SCCHN)
作者
Naamit Kurshan Gerber,Steve J. Chmura,J.J. Luke,Stephen Lawrence Shiao,Reva Kakkar Basho,Wade Thomas Iams,D. B. Page,C. Li,R.C. Gregory,M.H. Shaw,K.H. Horn,J. Gibbs,V.A. Appleman,A. Berger,Adnan O. Abu‐Yousif,Neil B. Lineberry,Kate F. Stumpo,A. Elfiky,B. Cooper
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
DW
hkk
aaaa
Zilaap
伯克利芙蓉王
吃葡萄不吐葡萄皮
Criminology34
彭于彦祖
v0id
123
坚强冰枫
123
乐空思
aajhajkahna
高贵千琴
Youdge
null
谢雷XIELei
152455
皖公网安备34019202002308
